Search

everythinglearnresearchcommunity

for

Search:↓

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

The Facial Psoriasis Log-based Area and Severity Index is a more effective way to measure improvements in facial psoriasis than the traditional method.

Hair loss in Chinese college students leads to various psychological issues, so treatment should address both hair loss and mental health.

The new system helps detect and track early female hair loss better.

Intense pulsed light with radiofrequency showed mixed results in improving quality of life for hidradenitis suppurativa patients, with no clinical improvements.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

Combining minoxidil with phototherapy improves vitiligo treatment better than phototherapy alone.

LiPADI is a useful tool for monitoring the severity and treatment of lichen planus.

The Thai version of the Family Dermatology Life Quality Index is a reliable and valid tool for assessing the quality of life of patients' families.

The Pemphigus Disease Area Index and Autoimmune Bullous Skin Disorder Intensity Score are the best tools for assessing pemphigus severity.

Aesthetic surgery improves body image and mental health, but pre-surgery psychological screening is important to manage expectations.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.

The STRIAA tool helps doctors quickly and effectively assess the severity of Alopecia Areata.

Higher BMI links to worse hair loss in Taiwanese men.

Alopecia areata severity is influenced by factors like long disease duration, relapses, treatment response, and mental health, leading to the creation of a new severity measurement tool.

Depression severity is not linked to PCOS markers like BMI, insulin resistance, or testosterone levels.

Clinicians should use evidence-based tools and consider mental health when assessing alopecia areata to guide treatment.

Severe Hidradenitis Suppurativa increases missed and unproductive workdays.

Higher apelin-12 levels may indicate more severe acne.

CLASI is a valid tool for assessing skin activity and damage in lupus patients.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

Oral isotretinoin and cyproterone compound are equally effective for treating acne in women with cutaneous hyperandrogenism.

Venusia CeraPlus cream and lotion effectively reduce eczema severity and improve skin moisture.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

The document focused on hair disorders, especially alopecia, and discussed treatments and impacts on quality of life.

Tapinarof cream at 1% concentration is effective and better tolerated for treating atopic dermatitis than the 2% concentration.

Low-dose acitretin helps nail psoriasis, stem cells may treat scarring alopecia, Chinese men have lower baldness rates, lateral foldplasty is good for ingrown toenails, hair diameter helps diagnose female baldness, childhood trauma linked to alopecia areata, certain hair-weaving leads to scalp conditions in African American women, and new methods for hair research and understanding hair and sweat gland development were introduced.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.